CH641570A5 - Process for the determination of an immunologically active material and reagent for carrying out this process - Google Patents

Process for the determination of an immunologically active material and reagent for carrying out this process Download PDF

Info

Publication number
CH641570A5
CH641570A5 CH246378A CH246378A CH641570A5 CH 641570 A5 CH641570 A5 CH 641570A5 CH 246378 A CH246378 A CH 246378A CH 246378 A CH246378 A CH 246378A CH 641570 A5 CH641570 A5 CH 641570A5
Authority
CH
Switzerland
Prior art keywords
enzyme
active material
immunologically active
receptor
ligand
Prior art date
Application number
CH246378A
Other languages
German (de)
English (en)
Inventor
Douglas E Hawley
Peter G Tonkes
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CH641570A5 publication Critical patent/CH641570A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CH246378A 1977-03-15 1978-03-07 Process for the determination of an immunologically active material and reagent for carrying out this process CH641570A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB10859/77A GB1595101A (en) 1977-03-15 1977-03-15 Enzyme modifier immunoassay

Publications (1)

Publication Number Publication Date
CH641570A5 true CH641570A5 (en) 1984-02-29

Family

ID=9975639

Family Applications (1)

Application Number Title Priority Date Filing Date
CH246378A CH641570A5 (en) 1977-03-15 1978-03-07 Process for the determination of an immunologically active material and reagent for carrying out this process

Country Status (16)

Country Link
JP (1) JPS53115814A (fr)
AT (1) AT367203B (fr)
AU (1) AU519326B2 (fr)
BE (1) BE864856A (fr)
CA (1) CA1102789A (fr)
CH (1) CH641570A5 (fr)
DE (1) DE2811257A1 (fr)
DK (1) DK152313C (fr)
ES (2) ES467831A1 (fr)
FR (1) FR2384262A1 (fr)
GB (1) GB1595101A (fr)
IL (1) IL54234A0 (fr)
IT (1) IT1158665B (fr)
NL (1) NL7802845A (fr)
NO (2) NO152955C (fr)
SE (1) SE447026B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273866A (en) 1979-02-05 1981-06-16 Abbott Laboratories Ligand analog-irreversible enzyme inhibitor conjugates and methods for use
GB2059421A (en) * 1979-10-03 1981-04-23 Self C H Assay method and reagents therefor
DE3006709A1 (de) * 1980-02-22 1981-08-27 Hans A. Dipl.-Chem. Dr. 8000 München Thoma Homogenes verfahren zur kompetitiven bestimmung von liganden
US4341865A (en) 1980-07-21 1982-07-27 Abbott Laboratories Determination of thyroxine binding globulin
FR2502786B1 (fr) * 1981-03-24 1985-06-21 Stallergenes Laboratoire Procede de fixation d'antigenes et d'anticorps sur support de polysaccharides, et utilisation du produit ainsi obtenu pour les dosages immunologiques
GB2116979B (en) * 1982-02-25 1985-05-15 Ward Page Faulk Conjugates of proteins with anti-tumour agents
AU574646B2 (en) * 1982-07-19 1988-07-14 Cooperbiomedical Inc. Enzyme assay method
GB2135773B (en) * 1983-01-31 1985-12-04 Boots Celltech Diagnostics Enzyme inhibitor labelled immunoassay
US4650751A (en) * 1983-04-29 1987-03-17 Technicon Instruments Corporation Protected binding assay avoiding non-specific protein interference
JPS607362A (ja) * 1983-06-27 1985-01-16 Fujirebio Inc 酵素を用いた抗原決定基具有物質の測定法
US4837395A (en) * 1985-05-10 1989-06-06 Syntex (U.S.A.) Inc. Single step heterogeneous assay
CA1330378C (fr) * 1986-05-08 1994-06-21 Daniel J. Coughlin Derives amine d'analogues de l'acide folique
US4939264A (en) * 1986-07-14 1990-07-03 Abbott Laboratories Immunoassay for opiate alkaloids and their metabolites; tracers, immunogens and antibodies
IL85596A (en) * 1987-05-18 1992-06-21 Technicon Instr Method for a specific binding enzyme immunoassay
US5972630A (en) * 1991-08-19 1999-10-26 Dade Behring Marburg Gmbh Homogeneous immunoassays using enzyme inhibitors
CA2107558A1 (fr) * 1992-03-04 1993-09-05 Nicholas Pomato Preciblage par double liaison in vivo
US5965106A (en) * 1992-03-04 1999-10-12 Perimmune Holdings, Inc. In vivo binding pair pretargeting
US6825000B1 (en) * 1998-05-15 2004-11-30 Sekisui Chemical Co., Ltd. Immunoassay reagent and immunoassay method
US6811998B2 (en) 1999-06-25 2004-11-02 Roche Diagnostics Operations, Inc. Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase
US8394813B2 (en) * 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
EP2131866B1 (fr) * 2007-02-16 2015-08-26 KTB Tumorforschungsgesellschaft mbH Promédicament à double action

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2308005A1 (fr) * 1975-04-15 1976-11-12 Hadaway Robert Element de fixation metallique

Also Published As

Publication number Publication date
NO152955C (no) 1985-12-18
ES467831A1 (es) 1979-09-01
NO154814C (no) 1986-12-29
JPS53115814A (en) 1978-10-09
ES475984A1 (es) 1979-06-16
IT1158665B (it) 1987-02-25
AT367203B (de) 1982-06-11
DK114778A (da) 1978-09-16
IL54234A0 (en) 1978-06-15
AU3396578A (en) 1979-09-13
IT7821256A0 (it) 1978-03-15
NO152955B (no) 1985-09-09
NL7802845A (nl) 1978-09-19
AU519326B2 (en) 1981-11-26
GB1595101A (en) 1981-08-05
CA1102789A (fr) 1981-06-09
DE2811257A1 (de) 1978-09-21
NO780902L (no) 1978-09-18
NO844764L (no) 1978-09-18
ATA182178A (de) 1981-10-15
BE864856A (fr) 1978-09-14
DK152313B (da) 1988-02-15
FR2384262A1 (fr) 1978-10-13
SE447026B (sv) 1986-10-20
FR2384262B1 (fr) 1983-04-08
NO154814B (no) 1986-09-15
SE7802923L (sv) 1978-09-16
DK152313C (da) 1988-09-26

Similar Documents

Publication Publication Date Title
CH641570A5 (en) Process for the determination of an immunologically active material and reagent for carrying out this process
DE2535574C2 (de) Verfahren zum Nachweis bzw. zur Bestimmung eines Liganden durch Fluoreszenzlöschung
DE2155658C3 (de) Verfahren zum Nachweis und zur Bestimmung von einem Hapten oder dessen Antikörper
DE2743444C3 (de) Immunchemisches Meßverfahren und Reagens zu seiner Durchführung
DE60035127T2 (de) Mit polysacchariden beschichtete träger, deren herstellung und verwendung
US4160016A (en) Receptor fluorescent immunoassay
DE3049711C2 (de) Ladungseffekte bei Immunassays
US4902630A (en) Fluorescence polarization immunoassy and reagents for measurement of c-reactive protein
DE69720809T2 (de) Durch gruppen erweiterte fluorophore polymere, die eine hydrophobe und konformativ eingeschrankte mikroumgebung schaffen
DE2913549A1 (de) Chemisch induzierter fluoreszenz- immuntest und testreagens zu dessen durchfuehrung
EP0407904B1 (fr) Procédé pour la détermination d'une analyte
DE112006003813T5 (de) Wasserlösliche Konjugate zur elektrochemischen Detektion
EP0697021B1 (fr) Derives photoactivables de la biotine et leur utilisation pour la suppression des interactions dans les dosages immunologiques
EP0291086B1 (fr) Procédé pour déterminer un anticorps dans des liquides du corps humain
DE2830862A1 (de) Homogener, kompetitiver antienzym- bindungstest und reagenz zur durchfuehrung des verfahrens
EP0349988B1 (fr) Méthode pour déterminer une substance spécifique capable de lier
DE4040669A1 (de) Verwendung von peptidpaaren mit extrem hoher spezifischer affinitaet zueinander im bereich der in vitro diagnostik
EP0356964A2 (fr) Méthode pour la détermination d'une substance de liaison spécifique
EP0034775A2 (fr) Procédé homogène pour la détermination sélective de ligands
DE69636013T2 (de) Verfahren zum erlangen von rezeptor-freigabeligand (reland)-komplexen und testansätze
DE60310012T2 (de) Verfahren, Assay und Kit zur Quantifizierung von HIV-Proteasehemmer
DE3629194A1 (de) Biotinylierungsreagentien
EP0747699B1 (fr) Réactif pour la suppression des interactions pour utilisation dans la détermination d'une analyte utilisant des complexes métalliques de marquage luminescent
DE10111224A1 (de) Analoge der Ecstasy-Klasse sowie Verwendung derselben beim Nachweis von Verbindungen der Ecstasy-Klasse
EP0303284B1 (fr) Procédé immunologique pour déterminer des substances hapténiques libres

Legal Events

Date Code Title Description
PL Patent ceased